ABOUT BAYBIO
GET INVOLVEDEVENT CENTERMEMBER CENTERINFORMATION CENTERMEDIA CENTER |
 |
BayBio Board of Directors Chairman
- David Martin, M.D.
Chief Executive Officer, Avid Biotics and Member, Board of Directors, Varian Medical Systems and Cubist Pharmaceuticals
Vice Chairman
- William Young
Chairman of the Board and Chief Executive Officer, Monogram Biosciences
Treasurer
Secretary
Members
-
Gregg Alton, J.D.
Senior Vice President and General Counsel, Gilead Sciences
- Michael Arbige, Ph.D.
Senior Vice President, Technology, Genencor International
- Robert Blum
President and CEO, Cytokinetics
- Eugene Bauer, M.D.
Chief Executive Officer, Neosil Incorporated
- Robert Brigham
Partner, Cooley Godward Kronish LLP
- G. Steven Burrill
Chief Executive Officer, Burrill & Company
- Peter Calcott, Ph.D.
Founder, Calcott Consulting
- Peter Daly
Senior Vice President, ABD Insurance
- Keith Donnermeyer
Life Sciences and Healthcare Regional Managing Partner, Deloitte & Touche LLP
- Kareem Dossa
Area Vice President of Sales, VWR International
- Matthew M. Gardner
President and Chief Executive Officer, BayBio
- Tom Glaze
Chief Executive Officer, Receptor Biologix
- Corey S. Goodman, Ph.D.
President and Chief Executive Officer, Renovis, Inc.
- Paul Hastings
President and Chief Executive Officer, OncoMed Pharmaceuticals
- Peter Hirth, Ph.D.
Chief Executive Officer, Plexxikon, Inc.
- Hoyoung Huh, Ph.D., M.D.
Chief Executive Officer, BiPar Sciences
- Steve James
President and Chief Executive Officer, KAI Pharmaceuticals
- James Karis
President and Chief Executive Officer, Entelos
- Todd Kaufman
Director, State Government Affairs, Genentech
- Caroline Loewy
Chief Financial Officer, Poniard Pharmaceuticals
- Gail Maderis
President & Chief Executive Officer, FivePrime Pharmaceuticals
- Alan C. Mendelson
Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP
- Susan Molineaux, Ph.D.
President and Chief Executive Officer, Proteolix, Inc.
- Phil Moody
Chief Financial Officer, Peplin
- Antoun Nabhan
Founder and Vice President of Operations and Investor Relations, Presidio Pharmaceuticals
- Daniel O'Day
President and Chief Executive Officer, Roche Molecular Diagnostics
- Lynn Pasahow, Esq.
Partner, Fenwick & West LLP
- Daniel Perez, M.D.
Venture Partner, Bay City Capital
- Jeffrey N. Peterson
Chief Executive Officer, Target Discovery, Inc.
- Glenn Pierce, Ph.D., M.D.
Vice President Preclinical Development and US Medical Affairs, Bayer Healthcare
- Kim Popovits
President and Chief Operating Officer, Genomic Health
- A. Franklin Rice
Senior Vice President of Finance and Administration, VistaGen
- Steve Richardson
Senior Vice President, Alexandria Real Estate Equities, Inc.
- George A. Scangos, Ph.D.
President & Chief Executive Officer, Exelixis Pharmaceuticals
- Anthony Stolis
Clarkston Consulting
- Dan Welch
Chief Executive Officer and President, InterMune
|
